Humana Inc: Form 10-Q for the period ended Jun 30, 2020
Filed with the SEC on Aug 5, 2020 and accepted by EDGAR at Aug 5, 2020, 14:02 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-04-01 to 2020-06-30 | $19.08bn | us-gaap:Revenues |
| Revenue | 6 months2020-01-01 to 2020-06-30 | $38.02bn | us-gaap:Revenues |
| Selling, general and administrative | 3 months2020-04-01 to 2020-06-30 | $2.35bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2020-01-01 to 2020-06-30 | $4.47bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-04-01 to 2020-06-30 | $2.44bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2020-01-01 to 2020-06-30 | $3.51bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2020-04-01 to 2020-06-30 | $76.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2020-01-01 to 2020-06-30 | $136.0m | us-gaap:InterestExpense |
| Income tax | 3 months2020-04-01 to 2020-06-30 | $783.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2020-01-01 to 2020-06-30 | $1.03bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-04-01 to 2020-06-30 | $1.83bn | us-gaap:NetIncomeLoss |
| Net income | 6 months2020-01-01 to 2020-06-30 | $2.30bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-04-01 to 2020-06-30 | $13.75 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2020-01-01 to 2020-06-30 | $17.31 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-04-01 to 2020-06-30 | $13.83 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2020-01-01 to 2020-06-30 | $17.41 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-04-01 to 2020-06-30 | 133,023,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2020-01-01 to 2020-06-30 | 132,917,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2020-01-01 to 2020-06-30 | $3.54bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2020-01-01 to 2020-06-30 | $418.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2020-01-01 to 2020-06-30 | $156.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2020-01-01 to 2020-06-30 | $25.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-06-30 | $7.16bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-06-30 | $27.87bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-06-30 | $38.45bn | us-gaap:Assets |
| Current liabilities | At period end2020-06-30 | $16.45bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-06-30 | $24.04bn | us-gaap:Liabilities |
| Long-term debt | At period end2020-06-30 | $6.06bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2020-06-30 | $1.72bn | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2020-06-30 | $14.42bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2020-06-30 | 132,292,566 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000049071-20-000106. Last ingested by Listed: Nov 6, 2026, 14:15 ET. Listed shows no prices and gives no investment advice.